×
About 258 results

ALLMedicine™ Viral Hemorrhagic Fevers Center

Research & Reviews  86 results

The development of broad-spectrum antiviral medical countermeasures to treat viral hemo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903284
PLoS Neglected Tropical Diseases; Hickman MR, Saunders DL et. al.

Mar 9th, 2022 - The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) began development of a broad-spectrum antiviral countermeasure against deliberate use of high-consequence viral hemorrhagic fevers (VHFs) i...

Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola)
https://clinicaltrials.gov/ct2/show/NCT04409405

Feb 17th, 2022 - Ebola virus is one of the most dangerous human pathogens and is an emerging public health problem in sub-Saharan Africa. Ebola virus disease (EVD) first appeared in 1976. The current epidemic in the Democratic Republic of the Congo (DRC) is one of...

A pigtailed macaque model of Kyasanur Forest disease virus and Alkhurma hemorrhagic dis...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638978
PLoS Pathogens; Broeckel RM, Feldmann F et. al.

Dec 3rd, 2021 - Kyasanur Forest disease virus (KFDV) and the closely related Alkhurma hemorrhagic disease virus (AHFV) are emerging flaviviruses that cause severe viral hemorrhagic fevers in humans. Increasing geographical expansion and case numbers, particularly...

Vector-borne and zoonotic infections and their relationships with regional and socioeco...
https://doi.org/10.1016/j.tmaid.2021.102174
Travel Medicine and Infectious Disease; Saydam FN, Erdem H et. al.

Oct 27th, 2021 - In this cross-sectional, international study, we aimed to analyze vector-borne and zoonotic infections (VBZI), which are significant global threats. VBZIs' data between May 20-28, 2018 was collected. The 24 Participatingcountries were classified a...

Bioterrorism.
https://www.ncbi.nlm.nih.gov/pubmed/34652097
American Family Physician; Rathjen NA, Shahbodaghi SD

Oct 16th, 2021 - Bioterrorism is the deliberate release of viruses, bacteria, toxins, or fungi with the goal of causing panic, mass casualties, or severe economic disruption. From 1981 to 2018, there were 37 bioterrorist attacks worldwide. The Centers for Disease ...

see more →

Clinicaltrials.gov  6 results

Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola)
https://clinicaltrials.gov/ct2/show/NCT04409405

Feb 17th, 2022 - Ebola virus is one of the most dangerous human pathogens and is an emerging public health problem in sub-Saharan Africa. Ebola virus disease (EVD) first appeared in 1976. The current epidemic in the Democratic Republic of the Congo (DRC) is one of...

Investigational Therapeutics for the Treatment of People With Ebola Virus Disease
https://clinicaltrials.gov/ct2/show/NCT03719586

Sep 8th, 2021 - Species Zaire ebolaviruses (EBOV) are members of the Filoviridae and are known primarily as the underlying cause of severe viral hemorrhagic fevers with disturbingly high case fatality rates. Between 1994 and the present, there have been many filo...

Convalescent Plasma Therapy for COVID-19 Patients
https://clinicaltrials.gov/ct2/show/NCT04565197

Dec 8th, 2020 - Passive immunization involves the administration of antibodies against a given agent to a susceptible individual for the purpose of preventing or treating an infectious disease due to that agent. A general principle of passive antibody therapy is ...

Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020
https://clinicaltrials.gov/ct2/show/NCT04352751

Sep 29th, 2020 - Passive immunization involves the administration of antibodies against a given agent to a susceptible individual for the purpose of preventing or treating an infectious disease due to that agent. A general principle of passive antibody therapy is ...

Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities
https://clinicaltrials.gov/ct2/show/NCT00992693

Jan 2nd, 2020 - Department of Defense operations have resulted in the deployment of personnel to areas endemic for Viral Hemorrhagic Fever (VHF): Crimean-Congo Hemorrhagic Fever (CCHF) or Lassa Fever. Unfortunately, beyond supportive care, there is no approved th...

see more →

News  7 results

Chemical-Biological Terrorism Response Plans Should Include Children
https://www.medscape.com/viewarticle/924339

Jan 29th, 2020 - NEW YORK (Reuters Health) - Children are disproportionately affected by chemical and biological events, so they must be included in the planning and response when terrorism strikes, according to a policy statement from the American Academy of Pedi...

UK Responds to Lassa Fever Outbreak in Nigeria
https://www.staging.medscape.com/viewarticle/893494

Mar 6th, 2018 - The UK Public Health Rapid Support Team (UK-PHRST) is being deployed to Nigeria as part of global efforts to control a Lassa fever outbreak. According to the Nigeria Centre for Disease Control, there have been 1,081 suspected cases of Lassa fever ...

UK Responds to Lassa Fever Outbreak in Nigeria
https://www.medscape.com/viewarticle/893494

Mar 6th, 2018 - The UK Public Health Rapid Support Team (UK-PHRST) is being deployed to Nigeria as part of global efforts to control a Lassa fever outbreak. According to the Nigeria Centre for Disease Control, there have been 1,081 suspected cases of Lassa fever ...

By the numbers
https://www.mdedge.com/dermatology/article/103573/practice-management/numbers
Alan Rockoff, MD

Oct 15th, 2015 - An old joke about old jokes: Three men have been friends for so long that to save time they tell jokes by number. “38,” says one.

Ebola entrenched in West Africa, recurrence inevitable
https://www.mdedge.com/chestphysician/article/88737/critical-care/ebola-entrenched-west-africa-recurrence-inevitable
Mitchel L. Zoler, PhD, MDedge News

Nov 17th, 2014 - VIENNA – The world had better get used to dealing with Ebola virus outbreaks, because even if the west African outbreak comes under control others will inevitably follow until an effective vaccine becomes widely used. On top of that, experts who g.

see more →

Patient Education  4 results see all →